A DNA enzyme to inhibit plasminogen activator inhibitor-1

Details for Australian Patent Application No. 2003231089 (hide)

Owner The Trustees of Columbia University in the City of New York

Inventors Itescu, Silviu

Agent FB Rice

Pub. Number AU-B-2003231089

PCT Number PCT/US03/12767

PCT Pub. Number WO2003/091456

Priority 10/128,706 23.04.02 US

Filing date 23 April 2003

Wipo publication date 10 November 2003

Acceptance publication date 4 December 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61K 31/37 (2006.01)

A61K 31/616 (2006.01)

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/727 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/02 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 10/128,706 23.04.02 US

18 December 2003 Application Open to Public Inspection

  Published as AU-B-2003231089

4 December 2008 Application Accepted

  Published as AU-B-2003231089

2 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003231090-Regeneration of endogenous myocardial tissue by induction of neovascularization

2003231088-N-acetylglucosaminyltransferase Vb coding sequence, recombinant cells and methods